INSIGHTS ON PHARMACEUTICAL INSPECTION
-
Part I: Defining The Dye Ingress Operating Window
Dye ingress testing depends on pressure dynamics that shift with viscosity. Discover how these constraints narrow its operating window and call into question its reliability for high‑risk applications.
-
The Sensitivity Trap: Building Confidence In CCIT Performance
Effective CCIT goes beyond micron claims, focusing instead on repeatability, confidence, and real‑world relevance. Learn how to define a defensible LOD and understand what auditors truly prioritize.
-
Pharma Product Inspection At Pack Expo 2023
Learn more about specialized inspection equipment for pharmaceutical products, including an X-ray for blister packs and a high-speed metal detector for tablets.
-
M6 Tablet Metal Detector For Pharmaceutical And Nutraceutical Production
Ensure the safety and quality of your tablets and capsules with a metal detector designed for stability and high sensitivity in pharmaceutical and nutraceutical production.
-
Innovation And Efficiency - Visual Inspection In The 21st Century9/22/2025
Digitizing your visual inspection processes is key to unlocking efficiency and ensuring compliance with global regulatory standards. Learn how to transition from paper-based systems to a digital database.
-
Increase Yield Through Reduced False Rejects6/15/2026
Protect your production yield and eliminate costly line disruptions. Watch this data-driven analysis to see how specialized inspection limits drastically lower false reject rates.
-
Maximum Quality Control6/9/2026
Precision inspection and compliance-driven processes are essential for manufacturing to help safeguard product quality, support regulatory requirements, and protect patient safety at scale.
-
Pharmaceutical Product Solutions6/16/2026
Discover how advanced inspection technologies, precise checkweighing, and data-driven automation secure pharmaceutical lines, protect product integrity, and ensure strict regulatory compliance.
-
USP Draft Chapters On CCS: What You Need To Know5/12/2026
Learn why it's important to stay aligned with evolving Annex 1 expectations to support sterility assurance, regulatory compliance, and patient safety across sterile drug manufacturing operations.
PHARMACEUTICAL INSPECTION SOLUTIONS
-
Developments in non-destructive, deterministic testing technologies that can achieve optimum assurance in container closure for biologics.
-
Discover a pathogen surveillance solution that delivers timely and highly reliable insight into in-air pathogen presence, so you can monitor and improve your facility safety protocols.
-
The Food and Drug Administration (FDA), United States Pharmacopeia (USP) and EMA Annex 1 issue strict guidelines for testing the integrity of IV bags and containers closed by fusion. IV bag manufacturers are one among many sterile product manufacturers that must meet these test requirements for container closure integrity.
-
Elevate production safety with high-speed detection that identifies small contaminants while reducing waste. Intuitive controls and durable design ensure long-term efficiency and reliability.
-
Our Switch 75 comes standard with an integrated de-/renester system, but can also be integrated into your production line via turn table or directly inline. Two inspection carousels allow the inspection of vials and syringes on one machine.